Brief: Grifols Achieves Self-Sufficiency In Plasma-Derived Medicines In Egypt

Grifols

04/12/2025 11:49

Dec 4 (Reuters) - Grifols SA GRLS.MC:

THROUGH GRIFOLS EGYPT FOR PLASMA DERIVATIVES (GEPD), HAS ACHIEVED CLINICAL SELF-SUFFICIENCY IN IMMUNOGLOBULINS, ALBUMIN, AND COAGULATION FACTORS FOR BLEEDING DISORDERS

CO CURRENTLY HAS 16 DONATION CENTRES IN EGYPT, WITH FOUR MORE TO BE ADDED IN 2026

Source text

Further company coverage: GRLS.MC

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com;))